Clinical Trials Logo
  1. Home
  2. Other
  3. NCT05083377
  4. Details
NCT05083377 Clinical Trial

Clozapine Use Pattern in the Province of Seville

Schizophrenia and Related Disorders Clinical Trial

Official title:
Clozapine Use Pattern in the Province of Seville

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT05083377
Other study ID # CLOZASEV
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 8, 2020
Est. completion date September 8, 2021

Study information
Verified date October 2021
Source Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

CLOZAPINE USE PATTERN IN THE PROVINCE OF SEVILLE

Description:

Subjects with a diagnosis of schizophrenia (F20 of ICD-10) under treatment with clozapine in the province of Seville. The use of clozapine, variability between centers and treatment modification will be identified.

Recruitment information / eligibility
Status Completed
Enrollment 600
Est. completion date September 8, 2021
Est. primary completion date September 8, 2021
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: Patients who have been prescribed (initially or regularly) clozapine during 2018, based on the casuistry provided by the Pharmacy service of the different hospitals. Exclusion Criteria: - Parkinson's disease - Dementia

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
Spain Hospital Universitario Virgen del Rocío Sevilla

Sponsors (1)
Lead Sponsor Collaborator
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Country where clinical trial is conducted

Spain, 

Outcome
Type Measure Description Time frame Safety issue
Primary Identify the pattern of clozapine use in the province of Seville Identify the pattern of clozapine use in the province of Seville year 2018
Secondary Analyze the variability between centers or professionals Analyze the variability between centers or professionals year 2018
Secondary Analyze the changes in the course of the disease since the prescription of clozapine Analyze the changes in the course of the disease since the prescription of clozapine year 2018
See also
  Status Clinical Trial Phase
Recruiting NCT06313918 - Exercise Therapy in Mental Disorders-study N/A
Recruiting NCT06134661 - Accelerated rTMS for Psychomotor Slowing N/A
Completed NCT01433094 - Study on Psychoeducation Enhancing Results of Adherence in Schizophrenia N/A
Terminated NCT05526833 - An Extension Protocol for Patients Who Previously Completed the TMS Pilot Study N/A
Recruiting NCT05982158 - Avatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Experiences of Hearing Voices N/A
Active, not recruiting NCT06175559 - Embedded Narrative in Interactive Game Design for Improving Medication Adherence of Schizophrenia N/A
Active, not recruiting NCT05673941 - "InMotion" - Physical Training With Creative Movement as an Intervention for Adults With Schizophrenia N/A
Recruiting NCT02916810 - TMS for Symptom Reduction in Schizophrenia N/A
Recruiting NCT03525054 - Semantic and Syntactic Computerized Analysis of Free Speech
Recruiting NCT05389345 - tDCS and Executive Function Training for Schizophrenia N/A
Completed NCT05601050 - Linguistic Predictors of Outcomes in Psychosis
Not yet recruiting NCT05958875 - The Effect of a Six Week Intensified Pharmacological Treatment for Schizophrenia Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. Phase 4
Completed NCT03075202 - Role of an E-cigarette on Smoking Displacement in Smokers With Schizophrenia
Completed NCT03921450 - Overcoming Psychomotor Slowing in Psychosis (OCoPS-P) N/A
Completed NCT06231407 - Increasing Medication Check Participation Through Applying CT-r N/A
Recruiting NCT04478838 - "Extended" (Alternate Day) Antipsychotic Dosing Phase 4
Completed NCT04366401 - Efficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic Disorders N/A
Completed NCT04612777 - A Trial of "Opening Doors to Recovery" for Persons With Serious Mental Illnesses N/A
Not yet recruiting NCT06191965 - MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction Phase 2/Phase 3
Recruiting NCT04321759 - Comparative Effectiveness of CET vs. SST in SMI (Serious Mental Illness) N/A